相关实验视频

Updated: Jul 21, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

酸衍生物准miR-361-3p/BTG2,在急性髓性白血病中产生抗癌作用

Shili Liu^1,2, Huijuan Xu³, Zhen Li¹

¹Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China.

Journal of biochemical and molecular toxicology

|July 27, 2023

概括

这项研究表明,9s-hydroxyoctadecadienoic acid (9s-HODE) 通过调节miR-361-3p/BTG2通路来对抗急性髓性白血病 (AML). 这种利诺基酸衍生物在AML治疗策略中表现有前途.

科学领域:

血液瘤学血液瘤学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

急性髓性白血病 (AML) 是一种严重的血液性恶性瘤,治疗选择有限.
了解新的分子通路对于开发有效的AML疗法至关重要.

研究的目的:

研究miR-361-3p和BTG2在AML中的作用.
探索9s-hydroxyoctadecadienoic acid (9s-HODE) 的抗AML作用及其潜在的分子机制.

主要方法:

定量实时逆转录聚合酶链反应 (qRT-PCR) 用于基因表达分析.
细胞活力测试 (CCK-8,EDU),流细胞计用于亡分析.
双露西法酶记者基因测定以确认miR-361-3p和BTG2的相互作用.

主要成果:

在AML中发现miR-361-3p和BTG2表达之间存在显著的负相关性.
9s-HODE降低了HL-60细胞活力,并诱导了亡.
miR-361-3p模仿和siBTG2抵消了9s-HODE的影响,证实了miR-361-3p/BTG2轴的参与.

结论:

9s-HODE通过调节miR-361-3p/BTG2轴来显示抗AML活性.
miR-361-3p/BTG2通路是急性髓性白血病的潜在治疗标.
9s-HODE是一种烯酸衍生物,为AML提供了潜在的治疗策略.

关键词:

9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadecadienoic 酸的9s-Hydroxyoctadec 在BTG2中使用BTG2.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.在 miR-361-3p 中使用.

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...